mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |